Benchling has raised $341.5M across 0 funding rounds, plus 4 undated rounds. The company is valued at $6.1B.
Benchling was founded in 2013, United States.
No date is disclosed for this round.
Each raise joins the axis with its own date and figures.
No filing has been made.
0 dated rounds, newest first.
Altimeter CapitalLEADSSequoia Capital Global EquitiesLEAD
Menlo VenturesLEAD
Thrive CapitalLEAD
Tiger GlobalSSequoia CapitalThe last valuation is $6.1B.
Lead investors for each round are in the funding timeline.
The closest biotech/research software peers are on the competitors page.
The routes section explains what is realistically available for a company at this stage.
No. Benchling is a private company; its shares do not trade on a public exchange.
Perpetual markets for stocks, gold, indices and pre-IPO names — settled on-chain, no wallet-to-exchange transfers.
